Healthcare Industry News:  ventricular assist device 

Devices Cardiology Personnel

 News Release - May 2, 2007

Ventracor: New Directors Strengthen Board

SYDNEY, Australia--(HSMN NewsFeed)--Ventracor Limited (ASX:VCR ) today announced the appointment of a new Non-Executive Director.


Mr William Curran, who joins the board effective immediately, is a New York-based company director with extensive experience in the medical device industry, including a 28-year career with Philips culminating in a senior role with Philips Medical Systems in USA.

Ventracor Chairman Mr John Massey said: "As Ventracor continues the evolution into a successful global medical device company, the Board will also evolve, and we are very pleased that we are able to attract such a talented and distinguished Director to join our team."

Mr Curran said: "I am delighted to be joining Ventracor at such an interesting time in the Company's development."

Mr Massey noted the Board expects to appoint another new US-based Director with complementary skills to Mr Curran later this year.

Ventracor CEO Mr Peter Crosby said: "The extensive knowledge and broad international experience of new Directors will complement the strong contributions and skills of the current Directors."

William E Curran had a successful career with Philips from 1976 until 2004, involving a mix of functional and senior general management experience. The 10 years at Philips Medical Systems included positions of Chief Operating Officer and Chief Financial Officer, and while at Philips Electronics North America, he was President and Chief Executive Officer and Chief Financial Officer. William is presently a Director of Resonant Medical, a company specializing in three dimensional ultrasound image guided adaptive radiotherapy products, and was formerly director of the NASDAQ listed companies: FEI Company; MedQuist, and Navigation Technologies. William holds an MBA from the University of Pennsylvania and a Bachelor of Science in Management Engineering from the Rensselaer Polytechnic Institute in New York.

About Ventracor

Ventracor is a global medical device company which produces an implantable blood pump, the VentrAssist left ventricular assist device (LVAD), as therapy to improve the lives of heart failure patients and their families. Ventracor is dedicated to building partnerships with healthcare professionals to make the VentrAssist the standard-of-care worldwide.

For further information, please visit www.ventracor.com. In Australia please contact John Massey, Chairman on +61 7 38684958 or Graeme Fallet, Company Secretary and Chief Financial Officer on + 61 2 9406 3100. Email: info@ventracor.com In the United States, please contact Douglas MacDougall, MacDougall Biomedical Communications +1(508)646-0209.


Source: Ventracor

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.